Annual accounts
Total Exemption Full accounts
30/09/2027Filing deadline
Made up to 31/12/2025Due 30/09/2027
- Next accounts made up to
- 31/12/2026
- Last accounts made up to
- 31/12/2025
SMI DRUG DISCOVERY LIMITED
ActiveRegistry details
Reference data exactly as held at Companies House.
Copy registry details
- Registered office
- Libra Building, 339 Exning Road, Newmarket, Suffolk CB8 0AT
- Classification (SIC)
- Research and experimental development on biotechnology (72.11 - SIC 2007)
- Accounts type
- Total Exemption Full
Company activity
The 4 most recent documents filed at Companies House.
Pre-Score for UK companies is coming soon
- 29/07/2026View PDF (4 pages)
Statement of capital following an allotment of shares on 2026-07-24
- 08/06/2026View PDF (1 pages)
Registered office address changed from 23 Longmeadow Lode Cambridge CB25 9HA United Kingdom to Libra Building 339 Exning Road Newmarket Suffolk CB8 0AT on 2026-06-08
- 02/04/2026View PDF (4 pages)
Statement of capital following an allotment of shares on 2026-04-01
- 02/03/2026View PDF (4 pages)
Statement of capital following an allotment of shares on 2026-01-30
Coming soon
What Pre-Score will tell you
- Whether the filed accounts are strengthening or weakening year on year.
- Whether this company files on time, and how often its record changes.
- How its officers and controlling parties connect to other UK companies.
Accounts and confirmation statement
The two filings Companies House requires every year, and where each one stands against its deadline today.
On schedule
Confirmation statement
Confirms the registry record is up to date
20/01/2027Filing deadline
Last statement 06/01/2026Due 20/01/2027
- Next statement date
- 06/01/2027
- Last statement dated
- 06/01/2026
Financial performance
The latest figures SMI DRUG DISCOVERY LIMITED filed. Okredo holds filed accounts data for 2021–2025; the year-by-year record is on the financials page.
Net Assets
£1.32M2025
16.58%vs 20242024: £1.13M
Total Assets
£1.58M2025
26.65%vs 20242024: £1.24M
Cash in Bank
£825.01K2025
23.36%vs 20242024: £668.81K
Total Liabilities
£162.84K2025
88.01%vs 20242024: £86.61K
Employees
142025
+1vs 20242024: 13
Of the 4 measures with an earlier filing to compare against, 4 rose. Total assets moved furthest, up 26.65% on 2024. See the full financial analysis for SMI DRUG DISCOVERY LIMITED.
The full financial record
Four ways through SMI DRUG DISCOVERY LIMITED's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Net Assets · +27.3% a year (CAGR)Three-year trend, 2023–2025Every measure end to end across 2023, 2024 and 2025, with the compound rate behind each one.See what moved5 chartsCharts by indicator5 filed indicators plotted year by year, 2021–2025.Plot the figuresNothing estimatedRatios from the filed figures4 ratios computed from this company's own reported amounts, each shown against the year it was derived from.Check the ratios5 × 5 yearsEvery figure by yearAll 5 measures Okredo tracks across 5 reported years, exactly as filed.Open the table
Employees
Headcount as reported to Companies House for 2021–2025.
| Year | Employees | Change |
|---|---|---|
| 2025 | 14 | +1 |
| 2024 | 13 | +1 |
| 2023 | 12 | +2 |
| 2022 | 10 | +9 |
| 2021 | 1 | – |
Reported employee count increased from 1 in 2021 to 14 in 2025. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
- Company potential
- Risk indicators
- Past performance
- Future prospects
Officers
5Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Director | 29/01/2018–Present | 0 | |
| Director | 03/07/2019–Present | 1 | |
| Director | 21/09/2021–Present | 6 | |
| Director | 21/09/2021–Present | 2 | |
| Director | 31/10/2025–Present | 0 |
Persons with significant control
5Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 28/01/2018–Present | 0 | |
| 29/01/2018–Present | 0 | |
| 31/01/2022–Present | 2 | |
| 29/01/2018–03/04/2025 | 0 | |
| 01/02/2022–Present | 2 |
Filing history and recent activity
Every document on the Companies House record, newest first.
- Filings on record
- 36
- Since 17/10/2022
- Last 12 months
- 9
- -2 vs the year before
- Most recent filing
- 29/07/2026
- 2 months ago
What changed in the last year
- Share capital (4)Latest 29/07/2026
- Registered officeLatest 08/06/2026
- Confirmation statementLatest 02/03/2026
- Officer changes (2)Latest 29/01/2026
Filing timeline
- 29/07/2026View PDF (4 pages)
Statement of capital following an allotment of shares on 2026-07-24
- 08/06/2026View PDF (1 pages)
Registered office address changed from 23 Longmeadow Lode Cambridge CB25 9HA United Kingdom to Libra Building 339 Exning Road Newmarket Suffolk CB8 0AT on 2026-06-08
- 02/04/2026View PDF (4 pages)
Statement of capital following an allotment of shares on 2026-04-01
- 02/03/2026View PDF (4 pages)
Statement of capital following an allotment of shares on 2026-01-30
- 02/03/2026View PDF (7 pages)
Confirmation statement made on 2026-01-06 with updates
- 29/01/2026View PDF (2 pages)
Director's details changed for Mr James John Clark on 2022-03-31
- 02/12/2025View PDF (32 pages)
Memorandum and Articles of Association
- 13/11/2025View PDF (4 pages)
Statement of capital following an allotment of shares on 2025-11-12
- 03/11/2025View PDF (2 pages)
Appointment of Mr Ronald Andrews as a director on 2025-10-31
- 29/09/2025View PDF (4 pages)
Statement of capital following an allotment of shares on 2025-09-26
- 24/09/2025View PDF (1 pages)
Cessation of Andrew James Thompson as a person with significant control on 2025-04-03
- 10/09/2025View PDF (4 pages)
Statement of capital following an allotment of shares on 2025-09-08
Showing 12 of 36 filings
See when the next accounts and confirmation statement are due
Similar companies
40 UK companies are similar to SMI DRUG DISCOVERY LIMITED, sharing the same company status (Active), the same industry sector and activity group (Research and experimental development on biotechnology) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
LINICAL UK LIMITED
ActiveMeacher-Jones, 6 St John's Court, Vicars Lane, Chester, Cheshire CH1 1QE
- Activity
- Research and experimental development on biotechnology
- Company no.
- 09318613
- Incorporated
- 19/11/2014
- Employees
- 13
BIOCORTEX LTD
Active167-169 Great Portland Street, London W1W 5PF
- Activity
- Research and experimental development on biotechnology
- Company no.
- 13287534
- Incorporated
- 23/03/2021
- Employees
- 13
LABOUR RESEARCH DEPARTMENT
Active3 St George's Mews, Westminster Bridge Road, London SE1 7JB
- Activity
- Research and experimental development on social sciences and humanities
- Company no.
- 11429402
- Incorporated
- 22/06/2018
- Employees
- 11
ALGAECYTES LIMITED
ActiveCamburgh House, 27 New Dover Road, Canterbury, Kent CT1 3DN
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 07264317
- Incorporated
- 25/05/2010
- Employees
- 13
APPLIED AGI LIMITED
Active1 Friar Street, Reading RG1 1DA
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 12211733
- Incorporated
- 17/09/2019
- Employees
- 14
About SMI DRUG DISCOVERY LIMITED
A short description of the company, written from its Companies House record.
SMI DRUG DISCOVERY LIMITED is a private limited company registered in the United Kingdom, based in Libra Building, 339 Exning Road, Newmarket, Suffolk CB8 0AT. Companies House classifies its business as Research and experimental development on biotechnology. It has been on the register for 8 years 8 months.
The register currently records it as active. Its 2025 accounts report net assets of £1.32M and 14 employees.
SMI DRUG DISCOVERY LIMITED: frequently asked questions
Answered from this company's own registry record and filed figures.
Companies House records SMI DRUG DISCOVERY LIMITED under one registered business activity: Research and experimental development on biotechnology (72.11 - SIC 2007).
SMI DRUG DISCOVERY LIMITED is recorded as active on the Companies House register, and has been on it since 29/01/2018.
The most recent accounts Okredo holds cover 2025 and report net assets of £1.32M, total assets of £1.58M, cash in bank of £825.01K and total liabilities of £162.84K.
The most recent document on the record is dated 29/07/2026: Statement of capital following an allotment of shares on 2026-07-24, 2 months ago.
On the current registry record, accounts are due by 30/09/2027 and the next confirmation statement is due by 20/01/2027.
Companies House lists 5 officers and 5 people with significant control (4 current).